Aveanna Healthcare (NASDAQ:AVAH) Price Target Raised to $15.00

Aveanna Healthcare (NASDAQ:AVAH) had its price target boosted by Barclays from $9.50 to $15.00 in a report issued on Friday morning,Benzinga reports. Barclays currently has an overweight rating on the stock.

Several other research firms also recently issued reports on AVAH. Raymond James Financial lifted their price target on Aveanna Healthcare from $13.00 to $15.00 and gave the stock a “strong-buy” rating in a research note on Friday, August 14th. Wall Street Zen downgraded shares of Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. Royal Bank Of Canada upped their price target on shares of Aveanna Healthcare from $10.00 to $16.00 and gave the company an “outperform” rating in a report on Monday, August 24th. UBS Group increased their price target on shares of Aveanna Healthcare from $8.00 to $13.00 and gave the company a “neutral” rating in a research report on Friday, August 14th. Finally, Truist Financial raised their price objective on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a research note on Monday, August 24th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $13.50.

Aveanna Healthcare Stock Performance

AVAH opened at $13.32 on Friday. Aveanna Healthcare has a 1-year low of $5.93 and a 1-year high of $14.00. The stock has a market cap of $2.91 billion, a P/E ratio of 10.83, a P/E/G ratio of 0.84 and a beta of 1.90. The stock’s 50 day simple moving average is $10.18 and its 200 day simple moving average is $8.11. The company has a debt-to-equity ratio of 4.47, a current ratio of 1.16 and a quick ratio of 1.16.

Aveanna Healthcare (NASDAQ:AVAH) last issued its quarterly earnings data on Thursday, August 13th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.05. The firm had revenue of $670.48 million during the quarter, compared to analysts’ expectations of $638.61 million. Aveanna Healthcare had a return on equity of 80.70% and a net margin of 10.56%. As a group, equities analysts anticipate that Aveanna Healthcare will post 0.75 EPS for the current fiscal year.

Insider Buying and Selling at Aveanna Healthcare

In other Aveanna Healthcare news, major shareholder Paul R. Vigano sold 14,500,002 shares of the firm’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $11.50, for a total transaction of $166,750,023.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, major shareholder J.H. Whitney Equity Partners V sold 12,496,077 shares of Aveanna Healthcare stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $143,704,885.50. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 79,746,745 shares of company stock worth $773,117,091. Corporate insiders own 5.30% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in AVAH. Dynamic Technology Lab Private Ltd grew its holdings in Aveanna Healthcare by 8.9% in the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock valued at $126,000 after buying an additional 1,151 shares during the period. Barclays PLC lifted its holdings in shares of Aveanna Healthcare by 0.8% during the 3rd quarter. Barclays PLC now owns 179,359 shares of the company’s stock worth $1,591,000 after acquiring an additional 1,366 shares during the period. Franklin Resources Inc. boosted its position in shares of Aveanna Healthcare by 4.5% in the third quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock worth $316,000 after acquiring an additional 1,528 shares during the last quarter. Intech Investment Management LLC boosted its position in shares of Aveanna Healthcare by 9.8% in the fourth quarter. Intech Investment Management LLC now owns 19,483 shares of the company’s stock worth $159,000 after acquiring an additional 1,739 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its position in shares of Aveanna Healthcare by 252.4% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after acquiring an additional 2,400 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.